Total Payments
$685.17
2019 Payments
$15.16
Companies
11
Transactions
41
Medicare Patients
973
Medicare Billing
$111,312
Payment Breakdown by Category
Food & Beverage$633.77 (92.5%)
Consulting$37.50 (5.5%)
Education$13.90 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.77 | 38 | 92.5% |
| Consulting Fee | $37.50 | 1 | 5.5% |
| Education | $13.90 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $199.28 | 14 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $113.55 | 6 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $87.67 | 4 | $0 (2018) |
| AbbVie, Inc. | $55.55 | 4 | $0 (2017) |
| Shire North American Group Inc | $51.60 | 3 | $0 (2017) |
| Corcept Therapeutics | $37.91 | 2 | $0 (2017) |
| Dexcom, Inc. | $36.96 | 2 | $0 (2018) |
| Lilly USA, LLC | $35.09 | 2 | $0 (2017) |
| Amgen Inc. | $34.42 | 2 | $0 (2017) |
| Medtronic MiniMed, Inc. | $19.73 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $15.16 | 1 | Novo Nordisk Inc ($15.16) |
| 2018 | $107.12 | 6 | SANOFI-AVENTIS U.S. LLC ($31.40) |
| 2017 | $562.89 | 34 | Novo Nordisk Inc ($165.07) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 11/27/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: DIABETES | ||||||
| 10/23/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 07/18/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Durable Pump | ||||||
| 04/10/2018 | Dexcom, Inc. | Dexcom CGM (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Endocrinology | ||||||
| 02/07/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: DIABETES | ||||||
| 11/07/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Endocrinology | ||||||
| 10/25/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2017 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $37.50 | General |
| Category: Diabetes | ||||||
| 10/04/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DIABETES | ||||||
| 09/26/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Endocrinology | ||||||
| 09/20/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: DIABETES | ||||||
| 06/06/2017 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $6.95 | General |
| Category: Diabetes | ||||||
| 05/17/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Obesity | ||||||
| 05/10/2017 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 05/10/2017 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: Diabetes | ||||||
| 05/03/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: DIABETES | ||||||
| 04/19/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 04/19/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: Diabetes | ||||||
| 04/18/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/11/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Endocrinology | ||||||
| 04/05/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 217 | 292 | $48,576 | $20,901 |
| 2022 | 5 | 208 | 364 | $47,992 | $27,781 |
| 2021 | 7 | 271 | 452 | $59,332 | $34,668 |
| 2020 | 6 | 277 | 468 | $58,202 | $27,961 |
Total Patients
973
Total Services
1,576
Medicare Billing
$111,312
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 128 | $22,033 | $10,993 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 52 | $5,800 | $2,855 | 49.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 38 | $5,966 | $2,319 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,677 | $1,435 | 18.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 19 | $2,135 | $1,277 | 59.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $1,800 | $1,070 | 59.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 15 | 15 | $2,240 | $537.40 | 24.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $925.00 | $416.59 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 178 | $28,124 | $16,531 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 102 | $10,608 | $5,745 | 54.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 43 | $4,300 | $2,624 | 61.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 25 | $3,750 | $2,229 | 59.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 15 | 16 | $1,210 | $651.92 | 53.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 201 | $31,758 | $19,083 | 60.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 107 | $11,128 | $6,484 | 58.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 39 | 55 | $5,400 | $3,698 | 68.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 25 | 32 | $4,616 | $3,119 | 67.6% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 20 | 21 | $5,250 | $1,704 | 32.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 13 | $950.00 | $511.41 | 53.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 23 | $230.00 | $69.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 227 | $35,866 | $17,065 | 47.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 116 | $12,064 | $5,217 | 43.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 33 | $3,432 | $2,548 | 74.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 32 | $2,400 | $1,650 | 68.7% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 16 | 16 | $4,000 | $1,350 | 33.8% |
About Dr. Jamal Merhy, M.D
Dr. Jamal Merhy, M.D is a Specialist healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720039332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamal Merhy, M.D has received a total of $685.17 in payments from pharmaceutical and medical device companies, with $15.16 received in 2019. These payments were reported across 41 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($633.77).
As a Medicare-enrolled provider, Merhy has provided services to 973 Medicare beneficiaries, totaling 1,576 services with total Medicare billing of $111,312. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism
- Location Lexington, KY
- Active Since 05/16/2006
- Last Updated 05/25/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720039332
Products in Payments
- Victoza (Drug) $127.09
- SOLIQUA (Drug) $82.15
- FARXIGA (Drug) $66.00
- Androgel (Drug) $55.55
- NATPARA (Drug) $51.60
- Korlym (Drug) $37.91
- Prolia (Biological) $34.42
- TOUJEO (Drug) $31.40
- Saxenda (Drug) $22.60
- Dexcom G5 Mobile CGM System (Device) $21.69
- BYDUREON (Drug) $21.67
- Minimed 670G System (Device) $19.73
- Xultophy 100/3.6 (Drug) $18.57
- TRULICITY (Drug) $17.61
- HUMALOG (Drug) $17.48
- Levemir (Drug) $15.86
- Dexcom CGM (Device) $15.27
- Ozempic (Drug) $15.16
- INVOKANA (Drug) $13.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lexington
Dr. Steven Waldman, M.d, M.D
Specialist — Payments: $119,557
Specialist $119,557
Magdalene Karon, Md, MD
Specialist — Payments: $16,628
Specialist $16,628
June Yong, Md, MD
Specialist — Payments: $12,010
Specialist $12,010
Dr. Warren Frank, Md, MD
Specialist — Payments: $9,353
Specialist $9,353
Mr. Joseph Bark, M.d, M.D
Specialist — Payments: $7,101
Specialist $7,101
Dr. Samy Elayi, Md, MD
Specialist — Payments: $5,948
Specialist $5,948